loadpatents
name:-0.01153302192688
name:-0.015036106109619
name:-0.00052905082702637
Ballinari; Dario Patent Filings

Ballinari; Dario

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ballinari; Dario.The latest application filed is for "therapeutic combination comprising a cdc7 inhibitor and an anti-neoplastic agent".

Company Profile
0.13.8
  • Ballinari; Dario - San Donato Milanese N/A IT
  • Ballinari; Dario - San Donato Milanese MI
  • Ballinari; Dario - Milan IT
  • Ballinari, Dario - Milanese IT
  • Ballinari, Dario - San Donato IT
  • Ballinari; Dario - S. Donato Milanese IT
  • Ballinari; Dario - S. Donato Mil. IT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Therapeutic combination comprising a Cdc7 inhibitor and an anti-neoplastic agent
Grant 9,119,877 - Ballinari , et al. September 1, 2
2015-09-01
Therapeutic combination comprising a PLK1 inhibitor and an antineoplastic agent
Grant 8,927,530 - Valsasina , et al. January 6, 2
2015-01-06
Therapeutic Combination Comprising A Cdc7 Inhibitor And An Anti-neoplastic Agent
App 20120276093 - Ballinari; Dario ;   et al.
2012-11-01
Therapeutic Combination Comprising A Plk1 Inhibitor And An Antineoplastic Agent
App 20120114641 - Valsasina; Barbara ;   et al.
2012-05-10
Therapeutic Combination Comprising An Aurora Kinase Inhibitor And Antiproliferative Agents
App 20110129467 - Pesenti; Enrico ;   et al.
2011-06-02
Therapeutic Combination Comprising An Aurora Kinase Inhibitor And An Antineoplastic Agent
App 20110117212 - Pesenti; Enrico ;   et al.
2011-05-19
Morpholinyl Anthracycline Derivative Combined With Protein Kinase Inhibitors
App 20100190736 - Geroni; Maria Cristina ;   et al.
2010-07-29
Therapeutic Combination Comprising an Aurora Kinase Inhibitor and Imatinib
App 20100022553 - Moll; Jurgen ;   et al.
2010-01-28
Pyridopyrimidinones derivatives as telomerase inhibitors
Grant 7,019,002 - Angiolini , et al. March 28, 2
2006-03-28
Aurones as telomerase inhibitors
App 20040132807 - Ballinari, Dario ;   et al.
2004-07-08
Pyridopyrimidinones derivatives as telomerase inhibitors
App 20040009993 - Angiolini, Mauro ;   et al.
2004-01-15
Anthracyclinone derivatives and their use in amyloidosis
Grant 6,096,888 - Suarato , et al. August 1, 2
2000-08-01
Aryl and heteroaryl purine compounds
Grant 5,965,563 - Buzzetti , et al. October 12, 1
1999-10-12
Substituted quinolymethylen-oxindole analogues as tyrosine kinase inhibitors
Grant 5,905,149 - Battistini , et al. May 18, 1
1999-05-18
Substituted indolylmethylene-oxindole analogues as tyrosine kinase inhibitors
Grant 5,849,710 - Battistini , et al. December 15, 1
1998-12-15
Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation
Grant 5,719,135 - Buzzetti , et al. February 17, 1
1998-02-17
Substituted azaindolylidene compounds and process for their preparation
Grant 5,663,346 - Buzzetti , et al. September 2, 1
1997-09-02
Biologically active 3-substituted oxindole derivatives useful as anti-angiogenic agents
Grant 5,576,330 - Buzzetti , et al. November 19, 1
1996-11-19
Vinylene-azaindole derivatives
Grant 5,397,787 - Buzzetti , et al. March 14, 1
1995-03-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed